)
)
Jing Colatat
Senior Scientist, Vaccine R&D
,
Pfizer
Jing Colatat is a Senior Scientist at Pfizer, specializing in advancing vaccine research and development through multiomics approaches. With extensive hands-on experience in Next and Third-Generation Sequencing, she is proficient with major sequencing platforms such as PacBio, Illumina, IonTorrent, and Nanopore.
During her tenure at Pfizer, Jing has developed and implemented many assays for short and long-read sequencing, to support the development of several key vaccines such as Comirnaty and ABRYSVO. In her spare time, she enjoys reading and hiking.
Sessions
-
Panel Discussion: How Do The Sequencing Technology Advancements Drive Translational Research?03-Jun-2026Innovation Stage